For individuals living with chronic conditions, stable housing enables consistent care. Conversely, housing instability can disrupt care continuity, increase financial strain, and contribute to ...

Capital Rx is now Judi Rx, maintaining a transparent pass-through PBM model while aligning brand architecture with the Judi ...

Symptom-based liver enzyme and triglyceride testing is proposed for isotretinoin patients without risk factors to reduce ...

Ambient-stable microneedle patches are positioned as a route to reduce refrigeration dependence and simplify administration ...

There will be a greater focus on surgical topics at the 2025 meeting of the American Society of Retina Specialists, compared with previous years, which reflects the need for balan ...

Retrospective Cleveland Clinic data (89 eyes) linked branded-to-bevacizumab switching with increased CST, shortened median injection interval (8.6 to 7.5 weeks), and 15.7% meeting poor-outcome ...

Dismissals occurred in 432 of 174,250 patients (0.25%), with noncompliance (60.2%) and aggressive or inappropriate conduct (18.2%) comprising the majority of cited reasons. Demographic differences ...

Preoperative statin exposure correlated with substantially reduced PVR incidence, the principal driver of rhegmatogenous retinal detachment repair failure, suggesting a potentially modifiable ...

IRIS Registry analysis captured first faricimab injections from Feb 2022–Sep 2023, requiring ≥12 months pre-index data and ≥24 months follow-up to characterize longitudinal real-world utilization.

Delinking PBM/GPO fees from list prices targets rebate-driven inflation that raises coinsurance and copays tied to inflated insulin list prices. Mandatory point-of-sale rebate pass-through and ...

IQVIA projects 118 U.S. biologics losing exclusivity by 2034 (~$234B opportunity), but only 12 had biosimilars in development as of Sept 2024, leaving most molecules uncontested. FDA draft guidance ...